Growth Metrics

Medpace Holdings (MEDP) Net Income towards Common Stockholders (2016 - 2026)

Medpace Holdings has reported Net Income towards Common Stockholders over the past 12 years, most recently at $123.9 million for Q1 2026.

  • Quarterly Net Income towards Common Stockholders rose 8.09% to $123.9 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $460.4 million through Mar 2026, up 10.57% year-over-year, with the annual reading at $451.1 million for FY2025, 11.56% up from the prior year.
  • Net Income towards Common Stockholders was $123.9 million for Q1 2026 at Medpace Holdings, down from $135.1 million in the prior quarter.
  • Over five years, Net Income towards Common Stockholders peaked at $135.1 million in Q4 2025 and troughed at $49.4 million in Q2 2022.
  • The 5-year median for Net Income towards Common Stockholders is $88.4 million (2024), against an average of $88.7 million.
  • Biggest five-year swings in Net Income towards Common Stockholders: soared 49.45% in 2024 and later grew 2.16% in 2025.
  • Tracing MEDP's Net Income towards Common Stockholders over 5 years: stood at $68.7 million in 2022, then grew by 14.02% to $78.3 million in 2023, then soared by 49.45% to $117.0 million in 2024, then rose by 15.48% to $135.1 million in 2025, then decreased by 8.33% to $123.9 million in 2026.
  • According to Business Quant data, Net Income towards Common Stockholders over the past three periods came in at $123.9 million, $135.1 million, and $111.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.